Neuberger Berman Group
CEMI

Neuberger Berman Group’s Chembio diagnostics, Inc. CEMI Stock Holding History

Neuberger Berman Group’s Portfolio CEMI Stock Details CEMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-37,500
Closed -$132K – 1876
2021
Q1 		$132K Hold
37,500
– – ﹤0.01% 1731
2020
Q4 		$178K Hold
37,500
– – ﹤0.01% 1638
2020
Q3 		$182K Hold
37,500
– – ﹤0.01% 1573
2020
Q2 		$122K Hold
37,500
– – ﹤0.01% 1508
2020
Q1 		$192K Buy
+37,500
New +$152K ﹤0.01% 1437
2016
Q2 		– Sell
-10,000
Closed -$60K – 1634
2016
Q1 		$60K Hold
10,000
– – ﹤0.01% 1469
2015
Q4 		$53K Buy
+10,000
New +$50.1K ﹤0.01% 1482

Other funds holding CEMI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TEE
Tibra Equities Europe London, United Kingdom $90.4M AUM 37.81% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Neuberger Berman Group's CEMI Position: Q2 2021 in Review

Neuberger Berman Group sold out of Chembio diagnostics, Inc. (CEMI) in Q2 2021, closing a stake of 37,500 shares — an estimated $132K sold.

Neuberger Berman Group first reported a position in CEMI in Q4 2015 and held it in 7 quarters. The position peaked at $192K in Q1 2020. 60 funds tracked by Wall St. Rank hold CEMI as of Q2 2021.

  • Neuberger Berman Group reported no remaining Chembio diagnostics, Inc. position as of Q2 2021 after selling out during the quarter.
  • Neuberger Berman Group sold 37,500 Chembio diagnostics, Inc. shares in Q2 2021, an estimated $132K.
  • Neuberger Berman Group first reported a position in Chembio diagnostics, Inc. in Q4 2015 and held it in 7 quarters.
  • Neuberger Berman Group's Chembio diagnostics, Inc. position peaked at $192K in Q1 2020.
  • 60 funds tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q2 2021.

Based on Neuberger Berman Group's 13F filing for Q2 2021, filed 13 Aug 2021.